Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Published protocols Phase 2 trials (Jastreboff 2023, NEJM) evaluated weekly subcutaneous doses of 1, 4, 8, and 12 mg in obesity research cohorts
Read more bit.ly/3PY1Sc3 Join the conversation
If you have an HSA, you can budget your GLP-1 cost across multiple years and carry a balance
Retatrutide has not received MHRA or EMA marketing authorisation and is only available within regulated clinical trials in the UK
Explore Supplement Packs Your Results Portal Every test, every report, every recommendation unified in one dashboard that updates as your biology evolves
Medical Disclaimer This article is for informational purposes only and does not constitute medical advice
US$ 23.44
US$ 28.95
US$ 22.18
US$ 27.08
US$ 22.77
